Investor Presentation Q1 2018 Audited Results

III Key Investment Highlights 2 Attractive Industry Dynamics (II/II) A highly defensive sector with significant room for continued growth Pharma Market Share Public Sector 3% Novartis 8% GSK 6% Market Segmentation | Market Share FY2017 ISP 19.2% Multinational 48% FY 2017 Others 56% Manu. GENERIC Private Sector 49% Sanofi 5% Pharco 5% Amoun 5% Others 31.8% Dist.1 UCP 32.9% Retail Other 92% Eipico 4% Eva 4% Pfizer 3% Hikma 2% Global Napi 2% POS 16.1% The distribution space is the most consolidated segment, with the 3 largest players processing 68% of the market sales Higher Priced Drug Pricing Adjustment Replacements Waves ibnsinapharma (1): Data for full year 2017 Source: IMS Health, BMI, WHO Growth Drivers IN Ezaby 4% Seif 2% Roushdy 2% Misr 1% Increasing Generic Uptake Increase of Chronic Diseases Ageing & Growing Population New Products - New Markets 13

View entire presentation